Filing Flows

Filing Flows › Baxter International (BAX) › Stock forecast & fair value

Baxter International (BAX) stock forecast and fair value

Baxter International (BAX) trades at $25.70. 12 analysts' median price target is $26.00 (+1%), from $23.00 to $40.00. Across 15 valuation methods the middle fair value is $25.24 (-2%).

Price$25.70
Median target$26.00
Fair value, middle$25.24
EPS beat rate80%
Baxter International fair value by method (price $25.70)Baxter International fair value by method (price $25.70)low – highpoint estimateEV/EBITDA vs peers$13.85EV/EBITDA vs peers, weighted$10.72EV/Sales vs peers$59.64EV/Sales vs peers, weighted$76.49EV/Sales vs peers, matched$30.97EV/Sales vs peers, growth & margin …$52.42Residual income$4.12Analysts' price targets$27.25Shareholder yield (dividends + buyb…$9.20Tangible book (asset value)$0.00

Fair value by method

MethodLowPointHighvs price
EV/EBITDA vs peers$8.37$13.85$20.78-46%
EV/EBITDA vs peers, weighted$7.10$10.72$14.67-58%
EV/Sales vs peers$38.37$59.64$113.69+132%
EV/Sales vs peers, weighted$52.41$76.49$127.50+198%
EV/Sales vs peers, matched$13.33$30.97$53.54+21%
EV/Sales vs peers, growth & margin adjusted$32.46$52.42$80.91+104%
Residual income$3.96$4.12$4.28-84%
Analysts' price targets$23.00$27.25$40.00+6%
Shareholder yield (dividends + buybacks)$8.11$9.20$10.62-64%
Tangible book (asset value)$0.00$0.00$0.00—

Baxter International's latest quarter

Baxter International, Q3 2026: revenue $3.0B (+5% year over year), operating margin 7.6%, net earnings $294M, operating cash flow $558M. The chart follows the revenue to costs, profit and cash.

Questions

What is the price target for BAX stock?

The median of 12 analysts' 12-month targets is $26.00, +1% from $25.70; the range is $23.00 to $40.00. The average rating is hold.

What is Baxter International's fair value?

The fair-value methods on Filing Flows (DCF, Monte Carlo, peer multiples and others) put it between $0.00 and $76.49, with a middle value of $25.24 against a price of $25.70. Each method's assumptions are on the page.

Does Baxter International usually beat earnings estimates?

It beat the consensus EPS estimate in 80% of the quarters on record.

Is BAX stock a buy?

Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.